BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25041609)

  • 61. Chronic Lymphocytic Leukemia: Prognostic Factors at Presentation in a Resource-Limited Center.
    Korubo KI; Okite UP; Ezeugwu SI
    JCO Glob Oncol; 2021 Jan; 7():56-62. PubMed ID: 33434067
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lymphocytosis and chronic lymphocytic leukaemia: investigation and management.
    Devi A; Thielemans L; Ladikou EE; Nandra TK; Chevassut T
    Clin Med (Lond); 2022 May; 22(3):225-229. PubMed ID: 35584829
    [TBL] [Abstract][Full Text] [Related]  

  • 63. B-chronic lymphocytic leukaemia in Latvia: epidemiological aspects.
    Yavorkovsky LI; Terebkova ZF; Nikulshin SV; Yavorkovsky LL
    Eur J Haematol; 1993 Oct; 51(4):214-7. PubMed ID: 8243610
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia.
    Cohen JA; Rossi FM; Zucchetto A; Bomben R; Terzi-di-Bergamo L; Rabe KG; Degan M; Steffan A; Polesel J; Santinelli E; Innocenti I; Cutrona G; D'Arena G; Pozzato G; Zaja F; Chiarenza A; Rossi D; Di Raimondo F; Laurenti L; Gentile M; Morabito F; Neri A; Ferrarini M; Fegan CD; Pepper CJ; Del Poeta G; Parikh SA; Kay NE; Gattei V
    Haematologica; 2020 Jun; 105(6):1613-1620. PubMed ID: 31582547
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed?
    Baliakas P; Mattsson M; Stamatopoulos K; Rosenquist R
    J Intern Med; 2016 Apr; 279(4):347-57. PubMed ID: 26709197
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Low activity of the classical complement pathway predicts short survival of patients with chronic lymphocytic leukaemia.
    Varga L; Czink E; Miszlai Z; Pálóczi K; Bányai A; Szegedi G; Füst G
    Clin Exp Immunol; 1995 Jan; 99(1):112-6. PubMed ID: 7813102
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prognosis of chronic lymphocytic leukemia: a multivariate regression analysis of 325 untreated patients.
    Lee JS; Dixon DO; Kantarjian HM; Keating MJ; Talpaz M
    Blood; 1987 Mar; 69(3):929-36. PubMed ID: 3814821
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Complications and causes of death in B cell chronic lymphocytic leukaemia: a long term study of 105 patients.
    Robertson TI
    Aust N Z J Med; 1990 Feb; 20(1):44-50. PubMed ID: 2322201
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Erythrocyte sedimentation rate as a prognostic factor in chronic lymphocytic leukaemia.
    Hannisdal E; Grøttum KA; Langmark F
    Scand J Haematol; 1986 Mar; 36(3):253-7. PubMed ID: 3704549
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Do we need to analyse everything at diagnosis in chronic lymphocytic leukaemia?
    Gribben JG
    Br J Haematol; 2020 May; 189(4):603-604. PubMed ID: 32037510
    [No Abstract]   [Full Text] [Related]  

  • 71. Correction to: The Italian validation of the communicative effectiveness index questionnaire: a multicentric study.
    Moretta P; Lanzillo A; Lo Sapio MD; Spaccavento S; Cellamare F; Nisoli F; Ianni A; Pain D; Feroldi S; Forlani CA; Boccola S; Madonia F; Volanti P; Pierobon A; Scola I; Manera M; Bertolotti G; Trojano L
    Neurol Sci; 2021 Jun; 42(6):2601. PubMed ID: 33856583
    [No Abstract]   [Full Text] [Related]  

  • 72. Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia.
    Wang J; Khiabanian H; Rossi D; Fabbri G; Gattei V; Forconi F; Laurenti L; Marasca R; Del Poeta G; Foà R; Pasqualucci L; Gaidano G; Rabadan R
    Elife; 2014 Dec; 3():. PubMed ID: 25496728
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL).
    Molica S; Giannarelli D; Levato L; Mirabelli R; Gentile M; Lentini M; Morabito F
    Int J Hematol; 2014 Sep; 100(3):290-5. PubMed ID: 25064370
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia.
    Morabito F; Tripepi G; Moia R; Recchia AG; Boggione P; Mauro FR; Bossio S; D'Arrigo G; Martino EA; Vigna E; Storino F; Fronza G; Di Raimondo F; Rossi D; Condoluci A; Colombo M; Fais F; Fabris S; Foa R; Cutrona G; Gentile M; Montserrat E; Gaidano G; Ferrarini M; Neri A
    Front Oncol; 2021; 11():684621. PubMed ID: 34408978
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
    Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prognostic models for chronic lymphocytic leukemia (CLL): a systematic review and meta-analysis.
    Molica S; Giannarelli D
    Leukemia; 2021 Feb; 35(2):615-618. PubMed ID: 32565543
    [No Abstract]   [Full Text] [Related]  

  • 77. Is Cd11c and Fmc7 Negativity in Chronic Lymphocytic Leukemia Poor Prognostic?
    Şentürk Yikilmaz A; Akinci S; Bakanay ŞM; Zengin ZB; Dilek İ
    Indian J Hematol Blood Transfus; 2020 Jan; 36(1):84-90. PubMed ID: 32158089
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inheritance of Susceptibility to Malignant Blood Disorders.
    Jønsson V; Awan H; Jones ND; Johannesen TB; Steig BÁ; Andosdottir G; Tjønnfjord GE
    Sci Rep; 2019 Feb; 9(1):2444. PubMed ID: 30792429
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Smudge cell percentage as a surrogate marker for ZAP-70 expression in patients with chronic lymphocytic leukemia.
    Al-Kahiry W; Tawfik HS; Sharshira H; Ghanem A; El-Gammal M; Mikhael IL
    Blood Res; 2018 Sep; 53(3):218-222. PubMed ID: 30310788
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia.
    Baliakas P; Moysiadis T; Hadzidimitriou A; Xochelli A; Jeromin S; Agathangelidis A; Mattsson M; Sutton LA; Minga E; Scarfò L; Rossi D; Davis Z; Villamor N; Parker H; Kotaskova J; Stalika E; Plevova K; Mansouri L; Cortese D; Navarro A; Delgado J; Larrayoz M; Young E; Anagnostopoulos A; Smedby KE; Juliusson G; Sheehy O; Catherwood M; Strefford JC; Stavroyianni N; Belessi C; Pospisilova S; Oscier D; Gaidano G; Campo E; Haferlach C; Ghia P; Rosenquist R; Stamatopoulos K;
    Haematologica; 2019 Feb; 104(2):360-369. PubMed ID: 30262567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.